Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Components of Accrued Liabilities (Detail)

v3.21.2
Balance Sheet Components - Components of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Accrued Liabilities Current [Abstract]    
General and administrative $ 1,219 $ 1,577
Clinical trial related costs 613 1,743
Non-clinical research and manufacturing operations 4,235 4,321
Payroll related 5,199 4,908
Other accrued expenses 39 26
Total Accrued liabilities $ 11,305 $ 12,575